Alaya.bio is at the forefront of innovation, actively engaged in the development of a groundbreaking targeting polymeric nanoparticle. This revolutionary technology is designed to significantly improve the transduction efficiency of quiescent cells, including T-cells, NK-cells, and stem cells. What sets our platform apart is its ability to eliminate the requirement for activation factors or cytokines. This unique approach resu...
Alaya.bio is at the forefront of innovation, actively engaged in the development of a groundbreaking targeting polymeric nanoparticle. This revolutionary technology is designed to significantly improve the transduction efficiency of quiescent cells, including T-cells, NK-cells, and stem cells. What sets our platform apart is its ability to eliminate the requirement for activation factors or cytokines. This unique approach results in a reduction of exhaustion in transduced cells while preserving their naive and memory phenotypes. Ultimately, our efforts aim to achieve superior clinical outcomes through enhanced cellular functionality.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.